anakinra vs. control
COVID-19 mild to moderate
baricitinib vs. standard of care
fostamatinib vs. standard of care
lenzilumab vs. placebo
ruxolitinib vs. standard of care
tocilizumab vs. control
tocilizumab vs. corticosteroids
tofacitinib vs. standard of care
An extraction panel is open